Renal functional and cardiovascular outcomes of partial nephrectomy versus radical nephrectomy for renal tumors: a systematic review and meta-analysis.

[1]  C. Meyer,et al.  Impact of comorbidities on acute kidney injury and renal function impairment after partial and radical tumor nephrectomy , 2021, Scandinavian journal of urology.

[2]  Jing Wang,et al.  Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study , 2021, Frontiers in Oncology.

[3]  I. Derweesh,et al.  Elevated preoperative C‐reactive protein is associated with renal functional decline and non‐cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC) , 2020, BJU international.

[4]  M. Walach,et al.  Perioperative Blood Transfusion Is a Predictor of Acute and Chronic Renal Function Deterioration after Partial and Radical Nephrectomy for Renal Cell Carcinoma , 2020, Urologia Internationalis.

[5]  A. Finelli,et al.  Long-term outcomes after radical or partial nephrectomy for T1a renal cell carcinoma: A population-based study. , 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[6]  J. Kaouk,et al.  Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score‐matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group , 2020, BJU international.

[7]  A. Garg,et al.  Partial vs. radical nephrectomy and the risk of all-cause mortality, cardiovascular, and nephrological outcomes. , 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[8]  S. Yoshida,et al.  Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications. , 2020, Clinical genitourinary cancer.

[9]  U. Capitanio,et al.  Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer. , 2020, European urology oncology.

[10]  Paras H Shah,et al.  Association of Partial versus Radical Nephrectomy with Subsequent Hypertension Risk Following Renal Tumor Resection. , 2019, The Journal of urology.

[11]  U. Capitanio,et al.  Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project) , 2019, World Journal of Urology.

[12]  J. Cheville,et al.  Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. , 2018, European urology.

[13]  A. Gavin,et al.  Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. , 2018, European journal of cancer.

[14]  A. Hakimi,et al.  Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Kwak,et al.  Partial versus Radical Nephrectomy for T1-T2 Renal Cell Carcinoma in Patients with Chronic Kidney Disease Stage III: a Multiinstitutional Analysis of Kidney Function and Survival Rate , 2018, Journal of Korean medical science.

[16]  David J. T. Marco,et al.  Predictors of new‐onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population‐based analysis , 2018, Journal of Surgical Oncology.

[17]  T. Saika,et al.  Renal Function after Nephrectomy Influences the Risk of Cardiovascular Events. , 2018, Acta medica Okayama.

[18]  J. Brooks,et al.  Incident CKD after Radical or Partial Nephrectomy. , 2017, Journal of the American Society of Nephrology : JASN.

[19]  E. Messing,et al.  Exploratory Subgroup Analyses of Renal Function and Overall Survival in European Organization for Research and Treatment of Cancer randomized trial of Nephron-sparing Surgery Versus Radical Nephrectomy. , 2017, European urology focus.

[20]  J. Cadeddu,et al.  Increased use of antihypertensive medications after partial nephrectomy vs. radical nephrectomy. , 2017, Urologic oncology.

[21]  Choung-Soo Kim,et al.  Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors , 2017, Journal of Korean medical science.

[22]  Xunbo Jin,et al.  Partial nephrectomy vs. radical nephrectomy for renal tumors: A meta-analysis of renal function and cardiovascular outcomes. , 2016, Urologic oncology.

[23]  Herng‐Ching Lin,et al.  Nephrectomy Type Was Not Associated with a Subsequent Risk of Coronary Heart Disease: A Population-Based Study , 2016, PloS one.

[24]  J. Townend,et al.  Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors , 2016, Hypertension.

[25]  M. Yiu,et al.  Partial nephrectomy for T1 renal cancer can achieve an equivalent oncological outcome to radical nephrectomy with better renal preservation: the way to go. , 2015, Hong Kong medical journal = Xianggang yi xue za zhi.

[26]  Jin Wook Kim,et al.  Oncologic and Functional Outcomes after Partial Nephrectomy Versus Radical Nephrectomy in T1b Renal Cell Carcinoma: A Multicenter, Matched Case-Control Study in Korean Patients , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[27]  I. Derweesh,et al.  Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score. , 2015, Urology.

[28]  A. Finelli,et al.  Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end‐stage renal disease (ESRD) , 2015, BJU international.

[29]  T. Lu,et al.  Risk of End-Stage Renal Disease after Cancer Nephrectomy in Taiwan: A Nationwide Population-Based Study , 2015, PloS one.

[30]  Hyung L. Kim,et al.  Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis , 2015, World Journal of Urology.

[31]  A. Danser,et al.  Hypertension Renin–Angiotensin–Aldosterone System Alterations , 2015 .

[32]  Paul Russo,et al.  New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors. , 2013, Urology.

[33]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[34]  Chang Seong Kim,et al.  Impact of partial nephrectomy on kidney function in patients with renal cell carcinoma , 2014, BMC Nephrology.

[35]  F. Dekker,et al.  Long-term risks for kidney donors. , 2014, Kidney international.

[36]  Y. Kyung,et al.  The Type of Nephrectomy Has Little Effect on Overall Survival or Cardiac Events in Patients of 70 Years and Older With Localized Clinical T1 Stage Renal Masses , 2014, Korean journal of urology.

[37]  E. Jonsson,et al.  Kidney function following partial or radical nephrectomy for renal cell carcinoma: A population-based study , 2013, Scandinavian journal of urology.

[38]  H. Jung,et al.  Renal Function Following Curative Surgery for Renal Cell Carcinoma: Who Is at Risk for Renal Insufficiency? , 2013, Korean journal of urology.

[39]  B. Shuch,et al.  Overall survival advantage with partial nephrectomy: A bias of observational data? , 2013, Cancer.

[40]  J. Pluznick.  Renal and cardiovascular sensory receptors and blood pressure regulation. , 2013, American journal of physiology. Renal physiology.

[41]  B. Lane,et al.  Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease. , 2013, The Journal of urology.

[42]  H. Jeon,et al.  Uric acid levels correlate with baseline renal function and high levels are a potent risk factor for postoperative chronic kidney disease in patients with renal cell carcinoma. , 2013, The Journal of urology.

[43]  S. Byun,et al.  Predictive factors for the development of chronic renal insufficiency after renal surgery: a multicenter study , 2013, International Urology and Nephrology.

[44]  M. Lapitan,et al.  Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. , 2012, European urology.

[45]  F. Montorsi,et al.  Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. , 2012, European urology.

[46]  A. Matsubara,et al.  Comparison of Renal Function after Partial Nephrectomy and Radical Nephrectomy for Renal Cell Carcinoma , 2012, Urologia Internationalis.

[47]  F. Roos,et al.  Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm. , 2012, Urology.

[48]  J. McKiernan,et al.  Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less. , 2011, The Journal of urology.

[49]  S. Baltacı,et al.  Comparison of radical and partial nephrectomy in terms of renal function: A retrospective cohort study , 2011, Scandinavian journal of urology and nephrology.

[50]  R. Sylvester,et al.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. , 2011, European urology.

[51]  J. Kaouk,et al.  Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival. , 2010, Urology.

[52]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials , 2010, Obstetrics and gynecology.

[53]  J. W. Lee,et al.  Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors. , 2009, Urology.

[54]  I. Derweesh,et al.  Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy , 2009, BJU international.

[55]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[56]  Paul Russo,et al.  Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? , 2009, The Journal of urology.

[57]  Y. Quiroz,et al.  Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis. , 2005, Kidney international.

[58]  Thomas McGinn,et al.  Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic) , 2004, Canadian Medical Association Journal.

[59]  R. Munver,et al.  Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology. , 2003, Urology.